Literature DB >> 32732272

Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation.

M Ravanelli1, A Grammatica2, M Maddalo3, M Ramanzin4, G M Agazzi1, E Tononcelli1, S Battocchio5, P Bossi6, M Vezzoli7, R Maroldi1, D Farina1.   

Abstract

BACKGROUND AND
PURPOSE: The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has increased in the period from the 1970s to 2004, due to increase of infection with human papilloma virus (HPV). This study aimed to examine the role of histogram analysis of the ADC in treatment response and survival prediction of patients with oropharyngeal squamous cell carcinoma and known human papillomavirus status.
MATERIALS AND METHODS: This was a retrospective single-center study. Following inclusion and exclusion criteria, data for 59 patients affected by T2-T4 (according to the 8th edition of the AJCC Cancer Staging Manual) oropharyngeal squamous cell carcinoma were retrieved. Twenty-eight had human papillomavirus-positive oropharyngeal squamous cell carcinoma, while 31 had human papillomavirus-negative oropharyngeal squamous cell carcinoma. All patients underwent a pretreatment MR imaging. Histogram analysis of ADC maps obtained by DWI (b = 0-1000 mm/s2) was performed on the central section of all of tumors. The minimum follow-up period was 2 years. Histogram ADC parameters were associated with progression-free survival and overall survival. Univariable and multivariable Cox models were applied to the data; P values were corrected using the Benjamini-Hochberg method.
RESULTS: At univariable analysis, both human papillomavirus status and mean ADC were associated with progression-free survival (hazard ratio = 0.267, P < .05, and hazard ratio  = 1.0028, P ≤ .05, respectively), while only human papillomavirus status was associated with overall survival (hazard ratio  = 0.213, P ≤ .05) before correction. At multivariable analysis, no parameter was included (in fact, human papillomavirus status lost significance after correction). If we separated the patients into 2 subgroups according to human papillomavirus status, ADC entropy was associated with overall survival in the human papillomavirus-negative group (hazard ratio  = 4.846, P = .01).
CONCLUSIONS: ADC and human papillomavirus status are related to progression-free survival in patients treated with chemoradiation for advanced oropharyngeal squamous cell carcinoma; however, this association seems to result from the strong association between ADC and human papillomavirus status.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 32732272      PMCID: PMC7658864          DOI: 10.3174/ajnr.A6695

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Authors:  Carole Fakhry; Qiang Zhang; Phuc Felix Nguyen-Tân; David I Rosenthal; Randal S Weber; Louise Lambert; Andy M Trotti; William L Barrett; Wade L Thorstad; Christopher U Jones; Sue S Yom; Stuart J Wong; John A Ridge; Shyam S D Rao; James A Bonner; Eric Vigneault; David Raben; Mahesh R Kudrimoti; Jonathan Harris; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2017-08-04       Impact factor: 44.544

2.  Prediction of local failures with a combination of pretreatment tumor volume and apparent diffusion coefficient in patients treated with definitive radiotherapy for hypopharyngeal or oropharyngeal squamous cell carcinoma.

Authors:  Kayoko Ohnishi; Yoshiyuki Shioyama; Masamitsu Hatakenaka; Katsumasa Nakamura; Koichiro Abe; Takashi Yoshiura; Saiji Ohga; Takeshi Nonoshita; Tadamasa Yoshitake; Torahiko Nakashima; Hiroshi Honda
Journal:  J Radiat Res       Date:  2011       Impact factor: 2.724

3.  In Reply to Fakhry et al.

Authors:  Paolo Bossi; Rosalba Miceli; Roberta Granata; Simona Naimo; Gabriele Infante; Laura Deborah Locati; Nicola Alessandro Iacovelli; Carlo Fallai; Ester Orlandi; Lisa Licitra
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-01       Impact factor: 7.038

Review 4.  Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Carole Fakhry
Journal:  Future Oncol       Date:  2018-09-28       Impact factor: 3.404

5.  Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.

Authors:  Maarten Lambrecht; Ben Van Calster; Vincent Vandecaveye; Frederik De Keyzer; Ilse Roebben; Robert Hermans; Sandra Nuyts
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

6.  Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.

Authors:  Ashok Srinivasan; Thomas L Chenevert; Ben A Dwamena; Avraham Eisbruch; Kuanwong Watcharotone; James D Myles; Suresh K Mukherji
Journal:  J Comput Assist Tomogr       Date:  2012 Jan-Feb       Impact factor: 1.826

7.  Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

Authors:  Sanjeev Chawla; Sungheon Kim; Lawrence Dougherty; Sumei Wang; Laurie A Loevner; Harry Quon; Harish Poptani
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

8.  Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings.

Authors:  Juliette P Driessen; Joana Caldas-Magalhaes; Luuk M Janssen; Frank A Pameijer; Nina Kooij; Chris H J Terhaard; Wilko Grolman; Marielle E P Philippens
Journal:  Radiology       Date:  2014-04-17       Impact factor: 11.105

9.  External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma.

Authors:  Ralph T H Leijenaar; Sara Carvalho; Frank J P Hoebers; Hugo J W L Aerts; Wouter J C van Elmpt; Shao Hui Huang; Biu Chan; John N Waldron; Brian O'sullivan; Philippe Lambin
Journal:  Acta Oncol       Date:  2015-08-12       Impact factor: 4.089

Review 10.  Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.

Authors:  Ann D King; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2016-08-19       Impact factor: 3.909

View more
  4 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

Review 2.  Diffusion-weighted MRI to detect early response to chemoradiation in cervical cancer: A systematic review and meta-analysis.

Authors:  Vanessa N Harry; Sunil Persad; Bharat Bassaw; David Parkin
Journal:  Gynecol Oncol Rep       Date:  2021-10-18

3.  The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient.

Authors:  Steve Connor; Mustafa Anjari; Christian Burd; Amrita Guha; Mary Lei; Teresa Guerrero-Urbano; Irumee Pai; Paul Bassett; Vicky Goh
Journal:  Br J Radiol       Date:  2021-12-20       Impact factor: 3.039

Review 4.  Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Authors:  Haoru Dong; Xinhua Shu; Qiang Xu; Chen Zhu; Andreas M Kaufmann; Zhi-Ming Zheng; Andreas E Albers; Xu Qian
Journal:  Virol Sin       Date:  2021-06-21       Impact factor: 4.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.